TabsDetailsBasic DetailsDate: Tuesday, October 29, 2019Medical Product: Makena, hydroxyprogesterone caproateHealth Outcome(s): exposure in pregnancyMeeting Details: View the Advisory Committee Meeting Materials hereAdditional InformationRelated Assessment(s): Hydroxyprogesterone Caproate and Progesterone Use During Pregnancy